Advertisement
Advertisement
U.S. markets open in 6 hours 49 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Vallon Pharmaceuticals, Inc. (VLON)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2844-0.0131 (-4.40%)
At close: 04:00PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
0
0
100
0
0
Operating Expense
8,487
9,259
4,888
3,154
4,314
Operating Income
-8,487
-9,259
-4,788
-3,154
-4,314
Net Non Operating Interest Income Expense
-8
-16
-34
-197.026
1.061
Other Income Expense
-266
-28
-
-113.045
-
Pretax Income
-8,761
-9,303
-4,822
-3,464
-4,313
Net Income Common Stockholders
-8,761
-9,303
-4,822
-3,464
-4,313
Diluted NI Available to Com Stockholders
-8,761
-9,303
-4,822
-3,464
-4,313
Basic EPS
-
-1.42
-0.78
-0.60
-0.74
Diluted EPS
-
-1.42
-0.78
-0.60
-0.74
Basic Average Shares
-
6,541
6,756
5,800
5,800
Diluted Average Shares
-
6,541
6,756
5,800
5,800
Total Operating Income as Reported
-8,487
-9,259
-4,788
-3,154
-4,314
Total Expenses
8,487
9,259
4,888
3,154
4,314
Net Income from Continuing & Discontinued Operation
-8,761
-9,303
-4,822
-3,464
-4,313
Normalized Income
-8,495
-9,214
-4,822
-3,351
-4,313
Interest Expense
8
16
34
-
-
Net Interest Income
-8
-16
-34
-197.026
1.061
EBIT
-8,753
-9,287
-4,788
-3,154
-4,314
EBITDA
-8,679
-
-
-
-
Reconciled Depreciation
74
73
75
15.735
0.612
Net Income from Continuing Operation Net Minority Interest
-8,761
-9,303
-4,822
-3,464
-4,313
Total Unusual Items Excluding Goodwill
-266
-89
-
-113.045
-
Total Unusual Items
-266
-89
-
-113.045
-
Normalized EBITDA
-8,413
-9,125
-4,713
-3,026
-4,313
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement